Wealthcreatures.com
1.42K subscribers
1.19K photos
48 videos
40 files
1.54K links
Visit us at www.wealthcreatures.com

Driven by Fundamentals and Leveraging Technicals.

All post are Only For Study & Educational Purpose.consult you Financial Advisor Before Investing or taking any position.
DISCLAIMER:We r Not SEBI REGISTERED ANALYST.
Download Telegram
In September'21
Lincoln pharms said that it is planning to launch Cephalosporin products soon.
The company has acquired a facility in Gujarat. Investment in capacity expansion & modernization of the facility. Acquisition & further CAPEX will be funded from internal accruals

During Q1 & Q2, promoter group of Lincoln Pharma increased holding in the company continuously, FII have also increased their Shareholding in Q2

Mahendra Patel MD, said, "We are confident to improve our growing no. of revenue, margins & profitability in FY22. Our strategic growth initiatives, product, and geographical expansion, operational efficiency and Debt-free status are likely to maximize value for all stakeholders

The company plans to introduce 6 to 7 new products in the domestic markets and expects 20 -25 new dossiers approval for the exports market. Exports to the EU Markets are likely to commence from Q4FY22.

Company is currently trading at PE near 10.5 on FY22 and PB of 2.17
Reliance New ENERGY Solar To Acquire 40% stake in SW SOLAR
Tcs Results effect on I.T STOCKS

OPPORTUNITY TO ADD WHERE WE FEEL NUMBERS WLD BE GOOD

TECH MAHINDRA
LOW - 1386
Support@ 1350/1300

MINDTREE
LOW - 4176
SUPPORT@ 4000/3890

LTI
LOW - 5610
support@ 5400/5300

LTTS
Low - 4490
support @4400/4320

Wipro
Low - 635
Support @ 610/590


S/L - 2% Below support
Wealthcreatures.com
BSOFT ALREADY holding from 167 Now Ready for Fresh Leg of Rally once closes above 442 Next Test Levels # 490/515/555++ Longterm - 666/888++
BSOFT

On Radar

Opportunity to add

COMING IN F&O FROM NOVEMBER SERIES

LOW - 423.60

Support @ 420/405

Need to close above 450 for next leg of Rally
Wealthcreatures.com
TATA POWER ๐Ÿ”‹ 172.50 FRESH RECORD HIGH LONG TERM REVISED TEST LEVELS # 300/444++
TATA POWER

Getting Ready For PAISA DOUBLE๐Ÿ”œ๐Ÿ”œ๐Ÿ”œ๐Ÿ”œ

Fresh 52wk High

187 ๐ŸŽฏ

96 To 187 Done โœ” Till Now
DEEPAK NITRITE

Our ๐ŸŒŸ ๐ŸŒŸ PERFORMER

FRESH ATH

2989 ๐Ÿ’š๐Ÿ’š
https://wealthcreatures.com/2020/03/22/corona-virus-covid-2019-nifty-12430-to-7833-opportunity-or-more-pain/

๐ŸŽฏNIFTY 1050p Points up from March'20 Lows
7511 To 18000

๐ŸŽฏWe Told Last Year we are Near bottom when Nifty was
@7833.

๐ŸŽฏThat we don't see Nifty Going below 7200 & Nifty Took "U" Turn From 7511.

Check POST

๐ŸŽฏTOLD WE ARE NEAR BOTTOM START ADDING QUALITY STOCKS

๐ŸŽฏIN MARCH/APRIL/MAY
LAST YEAR NO ONE WANTED TO INVEST IN EQUITIES # That was the best Time For INVESTMENT
( Life Time Opportunity)

๐ŸŽฏTODAY # NIFTY 10500 points up from Covid Lows # EVERY1 wants To invest Now

๐ŸŽฏFOMO # Fear of missing Out playing in markets currently

THINK SMART#ACT SMART
Wealthcreatures.com
Don't Forget To Book ๐Ÿ“ˆ PROFITS ๐Ÿ“ˆ AS PER RISK Markets are Getting Ready For some Healthy RETRACEMENT We see 18300 as fair value in short Term Longterm # 20000/21000/25000+ can be seen on NIFTY
KEEP booking ๐Ÿ“ˆ profits as per Risk

Nifty 18000++

Markets are either over valued or under valued

18300 is fair value as per our study for short term

In longterm we are bullish and Nifty can test much higher levels

CONCENTRATE ON STOCK SPECIFIC ACTION & SECTOR SPECIFIC

Markets can go beyond 18300 also

You can't sell at Top Nor You can't buy at Bottom

Know your risk
Keep booking profits as per risk or Keep Trailing
Mastek Q1 Fy22 numbers on 19th Oct and Concall on 20th oct.